| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |